XML 17 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($)
shares in Millions, $ in Millions
Total
Common Stock
Capital in Excess of Par Value
Retained Earnings
Accumulated Other Comprehensive Loss
Total Walmart Shareholders' Equity
Nonredeemable Noncontrolling Interest
Beginning balance (in shares) at Jan. 31, 2021   2,821          
Beginning balance at Jan. 31, 2021 $ 87,531 $ 282 $ 3,646 $ 88,763 $ (11,766) $ 80,925 $ 6,606
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Consolidated net income (loss) 2,811     2,730   2,730 81
Other comprehensive income (loss), net of income taxes 3,746       3,820 3,820 (74)
Dividends (6,200)     (6,200)   (6,200)  
Purchase of Company stock (in shares)   (21)          
Purchase of Company stock (2,832) $ (2) (112) (2,718)   (2,832)  
Dividends to noncontrolling interest (408)           (408)
Sale of subsidiary stock 75   18     18 57
Other (in shares)   5          
Other (131)   (128) 2   (126) (5)
Ending balance (in shares) at Apr. 30, 2021   2,805          
Ending balance at Apr. 30, 2021 84,592 $ 280 3,424 82,577 (7,946) 78,335 6,257
Beginning balance (in shares) at Jan. 31, 2021   2,821          
Beginning balance at Jan. 31, 2021 87,531 $ 282 3,646 88,763 (11,766) 80,925 6,606
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Consolidated net income (loss) 10,307            
Other comprehensive income (loss), net of income taxes 3,089            
Ending balance (in shares) at Oct. 31, 2021   2,778          
Ending balance at Oct. 31, 2021 90,757 $ 277 4,811 85,674 (8,488) 82,274 8,483
Beginning balance (in shares) at Apr. 30, 2021   2,805          
Beginning balance at Apr. 30, 2021 84,592 $ 280 3,424 82,577 (7,946) 78,335 6,257
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Consolidated net income (loss) 4,364     4,276   4,276 88
Other comprehensive income (loss), net of income taxes 48       (30) (30) 78
Purchase of Company stock (in shares)   (17)          
Purchase of Company stock (2,369) $ (2) (94) (2,273)   (2,369)  
Dividends to noncontrolling interest (10)           (10)
Sale of subsidiary stock 177   6     6 171
Other (in shares)   3          
Other 325   319 (8)   311 14
Ending balance (in shares) at Jul. 31, 2021   2,791          
Ending balance at Jul. 31, 2021 87,127 $ 278 3,655 84,572 (7,976) 80,529 6,598
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Consolidated net income (loss) 3,132     3,105   3,105 27
Other comprehensive income (loss), net of income taxes (705)       (512) (512) (193)
Dividends 45     45   45  
Purchase of Company stock (in shares)   (14)          
Purchase of Company stock (2,132) $ (1) (87) (2,044)   (2,132)  
Dividends to noncontrolling interest (6)           (6)
Sale of subsidiary stock 2,979   922     922 2,057
Other (in shares)   1          
Other 317   321 (4)   317  
Ending balance (in shares) at Oct. 31, 2021   2,778          
Ending balance at Oct. 31, 2021 90,757 $ 277 4,811 85,674 (8,488) 82,274 8,483
Beginning balance (in shares) at Jan. 31, 2022   2,761          
Beginning balance at Jan. 31, 2022 91,891 $ 276 4,839 86,904 (8,766) 83,253 8,638
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Consolidated net income (loss) 2,103     2,054   2,054 49
Other comprehensive income (loss), net of income taxes 275       268 268 7
Dividends (6,173)     (6,173)   (6,173)  
Purchase of Company stock (in shares)   (17)          
Purchase of Company stock (2,376) $ (2) (125) (2,249)   (2,376)  
Sale of subsidiary stock 35   24     24 11
Other (in shares)   4          
Other (155) $ 1 (151) (4)   (154) (1)
Ending balance (in shares) at Apr. 30, 2022   2,748          
Ending balance at Apr. 30, 2022 85,600 $ 275 4,587 80,532 (8,498) 76,896 8,704
Beginning balance (in shares) at Jan. 31, 2022   2,761          
Beginning balance at Jan. 31, 2022 91,891 $ 276 4,839 86,904 (8,766) 83,253 8,638
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Consolidated net income (loss) 5,483            
Other comprehensive income (loss), net of income taxes (2,490)            
Ending balance (in shares) at Oct. 31, 2022   2,701          
Ending balance at Oct. 31, 2022 80,123 $ 270 4,817 77,946 (10,780) 72,253 7,870
Beginning balance (in shares) at Apr. 30, 2022   2,748          
Beginning balance at Apr. 30, 2022 85,600 $ 275 4,587 80,532 (8,498) 76,896 8,704
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Consolidated net income (loss) 5,147     5,149   5,149 (2)
Other comprehensive income (loss), net of income taxes (1,671)       (1,396) (1,396) (275)
Purchase of Company stock (in shares)   (26)          
Purchase of Company stock (3,386) $ (3) (182) (3,201)   (3,386)  
Dividends to noncontrolling interest (434)           (434)
Sale of subsidiary stock 10   8     8 2
Other 321   259 39   298 23
Ending balance (in shares) at Jul. 31, 2022   2,722          
Ending balance at Jul. 31, 2022 85,587 $ 272 4,672 82,519 (9,894) 77,569 8,018
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Consolidated net income (loss) (1,767)     (1,798)   (1,798) 31
Other comprehensive income (loss), net of income taxes (1,094)       (886) (886) (208)
Dividends 43     43   43  
Purchase of Company stock (in shares)   (22)          
Purchase of Company stock (2,932) $ (2) (158) (2,772)   (2,932)  
Dividends to noncontrolling interest (10)           (10)
Sale of subsidiary stock 10   7     7 3
Other (in shares)   1          
Other 286   296 (46)   250 36
Ending balance (in shares) at Oct. 31, 2022   2,701          
Ending balance at Oct. 31, 2022 $ 80,123 $ 270 $ 4,817 $ 77,946 $ (10,780) $ 72,253 $ 7,870